Defence Therapeutics expands radiopharmaceutical development strategy
Defence Therapeutics says it is expanding its radiopharmaceutical development strategy with alpha and beta-emitter programs.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.